AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2022
Dec 9, 2022
35119_dirs_2022-12-09_84709866-c07b-4ed3-b030-21a72cd2696e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2022-12-08
Reporting Person: Donini Oreola (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-08 | Option (Right to Buy) | $0.54 | A | 80000 | Acquired | 2032-12-07 | Common Stock (80000) | Direct |
Footnotes
F1: The stock option vested immediately as to 20,000 shares and vests as to the remainder at a rate of 5,000 of the shares on each three (3) month anniversary of December 8, 2022.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3